August 19, 2016 09:35 AM EDT
R&D

Gold­en Tri­an­gle gets £75M in fresh ven­ture funds for Cam­bridge U spin­outs

John Carroll

Editor & Founder

To­day’s edi­tion of End­points in­cludes a new start­up in a boom­ing Kendall Square and a $1 bil­lion-plus biotech cam­pus for South San Fran­cis­co. So let …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times